D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Emerson Electric
EMR
|
+$577M |
| 2 |
Amazon
AMZN
|
+$538M |
| 3 |
Tesla
TSLA
|
+$501M |
| 4 |
Netflix
NFLX
|
+$352M |
| 5 |
Adobe
ADBE
|
+$342M |
Top Sells
| 1 |
Alibaba
BABA
|
+$945M |
| 2 |
NVIDIA
NVDA
|
+$485M |
| 3 |
CELG
Celgene Corp
CELG
|
+$460M |
| 4 |
ConocoPhillips
COP
|
+$344M |
| 5 |
Biogen
BIIB
|
+$322M |
Sector Composition
| 1 | Technology | 20.59% |
| 2 | Consumer Discretionary | 15.86% |
| 3 | Healthcare | 13.39% |
| 4 | Financials | 10.6% |
| 5 | Industrials | 9.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
VEDL
2026
DELISTED
Vedanta Limited American Depostary Shares (Each representing four equity shares)
VEDL
| $681K | ﹤0.01% |
78,879
+51,510
| +188% | +$445K |
|
2027
Banco de Chile
BCH
$15.2B
| $680K | ﹤0.01% |
+32,389
| New | +$680K |
|
|
ALX
2028
Alexander's
ALX
$1.25B
| $678K | ﹤0.01% |
2,051
-819
| -29% | -$271K |
|
|
GNC
2029
DELISTED
GNC Holdings, Inc.
GNC
| $678K | ﹤0.01% |
250,841
+227,492
| +974% | +$615K |
|
2030
Lexicon Pharmaceuticals
LXRX
$418M
| $676K | ﹤0.01% |
162,971
+147,109
| +927% | +$610K |
|
|
ELME
2031
Elme Communities
ELME
$1.51B
| $674K | ﹤0.01% |
+23,115
| New | +$674K |
|
|
CALA
2032
DELISTED
Calithera Biosciences, Inc
CALA
| $671K | ﹤0.01% |
5,877
+1,376
| +31% | +$157K |
|
2033
Arq
ARQ
$306M
| $670K | ﹤0.01% |
+63,823
| New | +$670K |
|
2034
Nucor
NUE
$32.4B
| $667K | ﹤0.01% |
11,851
-147,042
| -93% | -$8.28M |
|
|
HTLF
2035
DELISTED
Heartland Financial USA, Inc.
HTLF
| $662K | ﹤0.01% |
13,308
-3,452
| -21% | -$172K |
|
2036
New Oriental
EDU
$8.79B
| $659K | ﹤0.01% |
5,436
-48,828
| -90% | -$5.92M |
|
|
FG
2037
DELISTED
FGL Holdings Ordinary Shares
FG
| $659K | ﹤0.01% |
61,843
-51,056
| -45% | -$544K |
|
2038
Horizon Bancorp
HBNC
$833M
| $655K | ﹤0.01% |
34,476
-14,861
| -30% | -$282K |
|
|
PTE
2039
DELISTED
PolarityTE, Inc. Common Stock
PTE
| $652K | ﹤0.01% |
10,037
+1,637
| +19% | +$106K |
|
|
HSKA
2040
DELISTED
Heska Corp
HSKA
| $652K | ﹤0.01% |
6,788
-1,738
| -20% | -$167K |
|
|
ACB
2041
Aurora Cannabis
ACB
$274M
| $650K | ﹤0.01% |
2,523
+2,245
| +808% | +$578K |
|
2042
Camtek
CAMT
$3.98B
| $646K | ﹤0.01% |
59,659
-1,823
| -3% | -$19.7K |
|
2043
Gentherm
THRM
$1.06B
| $646K | ﹤0.01% |
14,542
+4,405
| +43% | +$196K |
|
|
ELVT
2044
DELISTED
Elevate Credit, Inc.
ELVT
| $643K | ﹤0.01% |
144,531
+5,544
| +4% | +$24.7K |
|
2045
NewMarket
NEU
$7.87B
| $640K | ﹤0.01% |
1,315
-7,593
| -85% | -$3.7M |
|
2046
Alaunos Therapeutics
TCRT
$5.1M
| $639K | ﹤0.01% |
902
+551
| +157% | +$390K |
|
|
VRS
2047
DELISTED
Verso Corporation
VRS
| $633K | ﹤0.01% |
35,096
-22,581
| -39% | -$407K |
|
|
ATRI
2048
DELISTED
Atrion Corp
ATRI
| $631K | ﹤0.01% |
840
-575
| -41% | -$432K |
|
2049
Pixelworks
PXLW
$61.8M
| $625K | ﹤0.01% |
13,286
+888
| +7% | +$41.8K |
|
|
TREC
2050
DELISTED
Trecora Resources
TREC
| $625K | ﹤0.01% |
87,400
+15,937
| +22% | +$114K |
|